Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

Male infertility is rapidly rising in India, yet remains a taboo topic. With 75% of men facing fertility issues and steroids ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

A team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to ...

A joint study conducted by the University of Bonn and the DZNE has confirmed early-stage brain inflammation in mice.

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the ...

Caribou is enrolling a 20-patient confirmatory cohort using the company's HLA matching strategy in the ANTLER Phase 1 clinical trial in second-line large B cell lymphoma (2L LBCL). In H2 2025, Caribou ...

With this level of control, scientists can fine-tune how nanomedicines interact with the human body. These new designs are ...

Here’s what Catholics should know about the dire wolves and what the Church might have to say about “resurrecting” extinct species of animals.

Liver cancer poses significant challenges due to its complex causes and resistance to conventional treatments, highlighting the need for innovative ...

Stephen Nakrosis - profile from The Wall Street Journal. News, articles, biography and photos.